Patents by Inventor Norbert A. Kienzle

Norbert A. Kienzle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of cancer involving mutated KRAS or BRAF genes
    Patent number: 8932588
    Abstract: The present invention provides a method of treating cancer in a subject wherein the cancer comprises mutated KRAS or BRAF genes. The method comprises administering to the subject an effective amount of an antibody or antigen binding fragment thereof wherein the antibody or antigen binding fragment thereof competes with SC104 for binding to the human colon cancer cell line Colo205.
    Type: Grant
    Filed: October 29, 2010
    Date of Patent: January 13, 2015
    Assignee: Teva Pharmaceuticals Australia Pty. Ltd.
    Inventors: Norbert A. Kienzle, Anthony G. Doyle, Tony Rowe
  • Treatment of Cancer Involving Mutated KRAS or BRAF Genes
    Publication number: 20120244151
    Abstract: The present invention provides a method of treating cancer in a subject wherein the cancer comprises mutated KRAS or BRAF genes. The method comprises administering to the subject an effective amount of an antibody or antigen binding fragment thereof wherein the antibody or antigen binding fragment thereof competes with SC104 for binding to the human colon cancer cell line Colo205.
    Type: Application
    Filed: October 29, 2010
    Publication date: September 27, 2012
    Applicant: Cephalon Australia PTY LTD
    Inventors: Norbert A. Kienzle, Anthony G. Doyle, Tony Rowe